金达莱：拟2.8亿元投资济慈医疗，投资要素发生变更

Core Viewpoint - The company plans to invest 280 million yuan in Yunnan Jici Medical Technology Co., Ltd., with changes in investment elements [1] Investment Details - The investment will be made in three phases: 150 million yuan upon completion of business registration, 50 million yuan after obtaining IIT permission, and the remaining amount after IND approval [1] - The board of directors has approved the aforementioned matters [1] Agreement and Risks - The company intends to reach a concerted action agreement with Hu Min [1] - Jici Medical faces operational, financial, research and development, and policy risks, leading to uncertainties in future performance and returns [1]